Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...

Background Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of ...

Researchers sought to determine the effect of COPD exacerbation risk for ASCVD hospitalization in patients with ASCVD.

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

A new study published in the journal of BMC Pulmonary Medicine showed that dyspnea (mMRC score 1.67), symptom load (CAT score ...

This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...

PATIENTS hospitalized with advanced obstructive emphysema are often nervous, anxious and tense, perhaps to a greater degree than the average hospital patient. Because of dyspnea and cough they ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.